CRISPR‐Cas9 technology and its application in haematological disorders

H Zhang, N McCarty - British journal of haematology, 2016 - Wiley Online Library
The recent advent of the Clustered Regularly Interspaced Short Palindromic Repeats
(CRISPR)‐CRISPR associated protein 9 (Cas9) system for precise genome editing has …

Therapeutic gene editing in haematological disorders with CRISPR/Cas9

TI Jensen, E Axelgaard, RO Bak - British journal of …, 2019 - Wiley Online Library
Summary The Clustered Regularly Interspaced Short Palindromic Repeats
(CRISPR)/CRISPR‐associated (Cas) 9 platform offers an efficient way of making precise …

CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders

L Ugalde, S Fañanas, R Torres… - Cytotherapy, 2023 - Elsevier
The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system has
revolutionized the gene editing field, making it possible to interrupt, insert or replace a …

[HTML][HTML] CRISPR to fix bad blood: a new tool in basic and clinical hematology

E González-Romero, C Martínez-Valiente… - …, 2019 - ncbi.nlm.nih.gov
Advances in genome engineering in the last decade, particularly in the development of
programmable nucleases, have made it possible to edit the genomes of most cell types …

[HTML][HTML] Technical considerations for the use of CRISPR/Cas9 in hematology research

MC Gundry, DP Dever, D Yudovich, DE Bauer… - Experimental …, 2017 - Elsevier
Highlights•Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 is a
powerful tool for genome editing in hematopoietic cells, including primary hematopoietic …

Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders

Y Chen, R Wen, Z Yang, Z Chen - Gene Therapy, 2022 - nature.com
The clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9
(CRISPR/Cas9) system is a versatile and convenient genome-editing tool with prospects in …

CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside

O Humbert, C Samuelson… - British journal of …, 2021 - Wiley Online Library
Genome editing therapies represent a significant advancement in next‐generation,
precision medicine for the management of haematological diseases, and CRISPR/Cas9 has …

[HTML][HTML] CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool

S Shojaei Baghini, ZR Gardanova, SAH Abadi… - Cellular & Molecular …, 2022 - Springer
The progress of genetic engineering in the 1970s brought about a paradigm shift in genome
editing technology. The clustered regularly interspaced short palindromic repeats/CRISPR …

CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia

AM Alayoubi, ZY Khawaji, MA Mohammed… - Annals of …, 2024 - Springer
Gene therapy represents a significant potential to revolutionize the field of hematology with
applications in correcting genetic mutations, generating cell lines and animal models, and …

[HTML][HTML] Utility of CRISPR/Cas9 systems in hematology research

D Lucas, HA O'Leary, BL Ebert, CA Cowan… - Experimental …, 2017 - Elsevier
Highlights•CRISPR/Cas9 overcomes limitations of earlier targeted nuclease-mediated
methods.•CRISPR/Cas9 allows for insertions/deletions of multiple alleles in a single …